Carl Spana
Founder at PALATIN TECHNOLOGIES, INC.
Net worth: 492 736 $ as of 2024-06-29
Carl Spana active positions
| Companies | Position | Start | End |
|---|---|---|---|
| PALATIN TECHNOLOGIES, INC. | Director/Board Member | 1996-05-31 | - |
| Chief Executive Officer | 2000-06-13 | - | |
| Founder | 1986-11-20 | - | |
| President | 2000-06-13 | - | |
RhoMed, Inc.
 RhoMed, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Palatin Technologies, Inc., RhoMed, Inc. operates as a biotechnology company. The company is based in Santa Fe, NM. | Director/Board Member | - | - |
| President | - | - | |
| Chief Tech/Sci/R&D Officer | 1995-06-30 | 1996-05-31 |
Career history of Carl Spana
Former positions of Carl Spana
| Companies | Position | Start | End |
|---|---|---|---|
Castle Group Ltd.
 Castle Group Ltd. Real Estate DevelopmentFinance Part of Places for People Group Ltd., Castle Group Ltd. is a holding British company with interests in residential property management and portable appliance testing. The company is based in Scarborough, UK. Castle Group was acquired by Paladin Group Ltd. on July 14, 2006 for $14.74 million. | Corporate Officer/Principal | 1993-05-31 | 1996-05-31 |
Paramount BioCapital Asset Management, Inc.
 Paramount BioCapital Asset Management, Inc. Investment ManagersFinance Founded in 1991 by Dr. Lindsay Rosenwald, Paramount BioCapital Asset Management, Inc. is a hedge fund manager located in New York City. The firm is a subsidiary of Paramount BioCapital, Inc. | Corporate Officer/Principal | 1993-05-31 | 1996-05-31 |
| Paramount Capital Investments LLC | Corporate Officer/Principal | 1996-05-31 | 1996-05-31 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 1991-06-30 | 1993-05-31 |
Microlin Bio, Inc. /Old/
 Microlin Bio, Inc. /Old/ Medical SpecialtiesHealth Technology Microlin Bio, Inc. is a pre-clinical stage biopharmaceutical company. It focuses on the development of miR-based diagnostics and therapeutics, including both antimiRs and miR mimics, to diagnose and treat cancer. The company was founded by Joseph Hernandez on July 30, 2013 and is headquartered in New York, NY. | Director/Board Member | - | - |
| AVAX TECHNOLOGIES, INC. | Director/Board Member | 1995-07-31 | - |
| Independent Dir/Board Member | 1995-07-31 | - |
Training of Carl Spana
| The Johns Hopkins University | Doctorate Degree |
| Rutgers State University of New Jersey | Undergraduate Degree |
Statistics
International
| United States | 9 |
| France | 2 |
| United Kingdom | 2 |
Operational
| Corporate Officer/Principal | 4 |
| Director/Board Member | 4 |
| President | 2 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
| Finance | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| PALATIN TECHNOLOGIES, INC. | Health Technology |
| AVAX TECHNOLOGIES, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Private companies | 5 |
|---|---|
RhoMed, Inc.
RhoMed, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Palatin Technologies, Inc., RhoMed, Inc. operates as a biotechnology company. The company is based in Santa Fe, NM. | Commercial Services |
Castle Group Ltd.
Castle Group Ltd. Real Estate DevelopmentFinance Part of Places for People Group Ltd., Castle Group Ltd. is a holding British company with interests in residential property management and portable appliance testing. The company is based in Scarborough, UK. Castle Group was acquired by Paladin Group Ltd. on July 14, 2006 for $14.74 million. | Finance |
Paramount BioCapital Asset Management, Inc.
Paramount BioCapital Asset Management, Inc. Investment ManagersFinance Founded in 1991 by Dr. Lindsay Rosenwald, Paramount BioCapital Asset Management, Inc. is a hedge fund manager located in New York City. The firm is a subsidiary of Paramount BioCapital, Inc. | Finance |
| Paramount Capital Investments LLC | |
Microlin Bio, Inc. /Old/
Microlin Bio, Inc. /Old/ Medical SpecialtiesHealth Technology Microlin Bio, Inc. is a pre-clinical stage biopharmaceutical company. It focuses on the development of miR-based diagnostics and therapeutics, including both antimiRs and miR mimics, to diagnose and treat cancer. The company was founded by Joseph Hernandez on July 30, 2013 and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Carl Spana
- Experience
